An AllTrials project

NCT04375657: An ongoing trial by Intervene Immune, Inc.

This trial is ongoing. It must report results 1 year from now.

Full data

Full entry on ClinicalTrials.gov NCT04375657
Title Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Nov. 23, 2020
Completion date Dec. 31, 2025
Required reporting date Dec. 31, 2026, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Dec. 12, 2025
Days late None